NEW YORK (GenomeWeb News) – Roche today said that Molecular Diagnostic sales rose 4 percent year over year at constant exchange rates, while Diagnostic Division revenues were up also 4 percent in the second quarter.

Molecular Diagnostics increased to to CHF411 million ($439.9 million) from CHF395 million as Diagnostic Division revenues increased to CHF2.71 billion from CHF2.61 billion

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.

The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.

In Nature this week: investigation into the genetics of medulloblastoma, and more.

A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.